Literature DB >> 11062275

Prediction of functional outcome and in-hospital mortality after admission with oral anticoagulant-related intracerebral hemorrhage.

J Berwaerts1, R S Dijkhuizen, O J Robb, J Webster.   

Abstract

BACKGROUND AND
PURPOSE: Early survival of patients with intracerebral hemorrhage in general is known to be most strongly dependent on the Glasgow Coma Scale score on admission. The aim of this study was to examine the factors determining functional outcome and in-hospital mortality of patients admitted with an intracerebral hemorrhage related to oral anticoagulant (OAC) use.
METHODS: Correlation studies and multiple logistic regression analyses were performed on data from a retrospective series of 42 patients admitted with OAC-related intracerebral hemorrhages over a 6-year period to a tertiary care center in the north of Scotland.
RESULTS: The functional outcome after an OAC-related intracerebral hemorrhage was dependent on maximum diameter of hematoma on CT scan (R:=-0.72, P:<0. 001) and international normalized ratio (INR) (R:=-0.35, P:=0.024). Hematoma diameter and INR were not themselves strongly correlated (R:=0.31, P:=0.099). In-hospital mortality can be predicted by the Glasgow Coma Scale score alone (R:(2)=0.36, overall predictive accuracy 68%) but more accurately by a logistic regression model including hematoma diameter and CT signs of cerebrovascular disease (R:(2)=0.70, predictive accuracy 83%).
CONCLUSIONS: Neither functional outcome nor in-hospital mortality appears to be strongly dependent on INR measured on admission. CT scan, however, provides essential information and allows accurate predictions about the short-term outcome of OAC-related intracerebral hemorrhages.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11062275     DOI: 10.1161/01.str.31.11.2558

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  24 in total

1.  Death and disability from warfarin-associated intracranial and extracranial hemorrhages.

Authors:  Margaret C Fang; Alan S Go; Yuchiao Chang; Elaine M Hylek; Lori E Henault; Nancy G Jensvold; Daniel E Singer
Journal:  Am J Med       Date:  2007-05-24       Impact factor: 4.965

Review 2.  Applicability and relevance of models that predict short term outcome after intracerebral haemorrhage.

Authors:  M J Ariesen; A Algra; H B van der Worp; G J E Rinkel
Journal:  J Neurol Neurosurg Psychiatry       Date:  2005-06       Impact factor: 10.154

Review 3.  Oral anticoagulant-associated intracerebral hemorrhage.

Authors:  Alvaro Cervera; Sergio Amaro; Angel Chamorro
Journal:  J Neurol       Date:  2011-07-05       Impact factor: 4.849

4.  Previous antiplatelet therapy is an independent predictor of 30-day mortality after spontaneous supratentorial intracerebral hemorrhage.

Authors:  Jaume Roquer; Ana Rodríguez Campello; Meritxell Gomis; Angel Ois; Victor Puente; Elvira Munteis
Journal:  J Neurol       Date:  2005-03-03       Impact factor: 4.849

Review 5.  Warfarin reversal.

Authors:  J P Hanley
Journal:  J Clin Pathol       Date:  2004-11       Impact factor: 3.411

6.  Warfarin use leads to larger intracerebral hematomas.

Authors:  M L Flaherty; H Tao; M Haverbusch; P Sekar; D Kleindorfer; B Kissela; P Khatri; B Stettler; O Adeoye; C J Moomaw; J P Broderick; D Woo
Journal:  Neurology       Date:  2008-09-30       Impact factor: 9.910

Review 7.  [Intracerebral hemorrhage related to anticoagulant therapy].

Authors:  H B Huttner; E Jüttler; A Hug; M Köhrmann; P D Schellinger; T Steiner
Journal:  Nervenarzt       Date:  2006-06       Impact factor: 1.214

8.  The challenge of designing a treatment trial for warfarin-associated intracerebral hemorrhage.

Authors:  Matthew L Flaherty; Opeolu Adeoye; Padmini Sekar; Mary Haverbusch; Charles J Moomaw; Haiyang Tao; Joseph P Broderick; Daniel Woo
Journal:  Stroke       Date:  2009-03-12       Impact factor: 7.914

Review 9.  Warfarin-associated intracerebral hemorrhage.

Authors:  Anna Cavallini; Simona Fanucchi; Alessandra Persico
Journal:  Neurol Sci       Date:  2008-09       Impact factor: 3.307

Review 10.  Frequency of adverse events in patients with poor anticoagulation: a meta-analysis.

Authors:  Natalie Oake; Dean A Fergusson; Alan J Forster; Carl van Walraven
Journal:  CMAJ       Date:  2007-05-22       Impact factor: 8.262

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.